Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 549

Results For "ENT"

9439 News Found

Norms for fixing prices of medicines
Policy | December 20, 2023

Norms for fixing prices of medicines

NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201


Venus Remedies' R3SET forays into wellness
News | December 20, 2023

Venus Remedies' R3SET forays into wellness

The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey


Briefs: Aurobindo Pharma and Granules Pharmaceuticals
Drug Approval | December 20, 2023

Briefs: Aurobindo Pharma and Granules Pharmaceuticals

Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection


Vijaya Diagnostic to acquire P H Diagnostic for Rs. 134.65 Cr
News | December 20, 2023

Vijaya Diagnostic to acquire P H Diagnostic for Rs. 134.65 Cr

Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt


Sanofi India appoints Himanshu Bakshi as GM - Consumer Healthcare Business
People | December 19, 2023

Sanofi India appoints Himanshu Bakshi as GM - Consumer Healthcare Business

His most recent stint was with Danone India as its Managing Director


Biocon Academy conducts 8th Graduation Day
News | December 19, 2023

Biocon Academy conducts 8th Graduation Day

Five batches across four programs of Biocon Academy participated in the graduation ceremony


Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease
Drug Approval | December 18, 2023

Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease

Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation


Zydus receives final approval from the USFDA for Lacosamide Tablets
Drug Approval | December 18, 2023

Zydus receives final approval from the USFDA for Lacosamide Tablets

Lacosamide is indicated to treat partial-onset seizures


Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries
News | December 18, 2023

Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries

10+ emerging markets, Japan & ANZ transition in final phase